A review of recent insider activity at Snowflake Inc. (NASDAQ:SNOW) reveals that director Frank Slootman executed substantial sales of common stock on May 26, 2026. These transactions involved the disposal of common stock valued at approximately $9.77 million. It is important to note that these sales were carried out under the framework of a pre-arranged 10b5-1 trading plan, which had been adopted by him on September 19, 2025.
In addition to the divestment, Slootman engaged in an acquisition transaction on the same day. Specifically, he acquired 55,350 shares of common stock through the exercise of vested stock options. The cost basis for this option was $8.88 per share, resulting in a total value for the acquired shares of $491,508.
The sales component accounted for a total of 55,350 shares of Snowflake common stock. These shares were sold across multiple transactions, with reported prices ranging between $175.00 and $178.08 per share. The weighted-average selling prices calculated from these varied transactions were documented as $175.466, $176.419, and $177.498.
Following the reported sales, Snowflake's stock has experienced a significant upward trajectory. In the week immediately following these specific transactions, the stock price surged by 44.5%. Currently, shares are trading at $239.20, positioning them considerably above the sale prices utilized by Slootman.
From an analytical perspective, InvestingPro analysis currently suggests that the stock appears overvalued relative to its calculated Fair Value. Despite this valuation assessment, the company's market capitalization stands at $82.7 billion. This substantial market size is underpinned by strong financial metrics, including a reported 31% revenue growth. However, the source material also indicates that Snowflake remains unprofitable when viewed over the last twelve months.
The director’s holdings following these transactions provide further insight into his current stake. After selling the shares, Slootman directly retained an ownership of 38,046 shares of Snowflake common stock. This reported figure incorporates shares that are slated to be issued in connection with the vesting of restricted stock units.
Furthermore, Slootman maintains significant indirect holdings through several trusts. These include 16,300 shares held via the Slootman Grandchildren’s Trust, 78,893 shares managed by the Slootman 2023 Children’s Trust, and 56,331 shares each within both the F. Slootman 2024 Grantor Retained Annuity Trust and the B. Slootman 2024 Grantor Retained Annuity Trust. In terms of trusteeship, Slootman serves as a trustee for the first three named trusts, while his spouse holds the role of trustee for the B. Slootman 2024 Grantor Retained Annuity Trust.
Beyond insider activity, Snowflake Inc. has recently reported robust financial results for the first quarter of fiscal year 2027. These strong performance indicators have prompted several analyst firms to raise their price targets for the company.
During that quarter, Snowflake's product revenue reached $1.334 billion. This figure represents a substantial 33.9% increase compared to the previous year and surpassed FactSet consensus expectations by 5.3%. The company's operating income also exceeded estimates by 35.2%, underscoring its strong financial operational performance.
Specific analyst actions include:
- Monness, Crespi, Hardt increased their price target to $320, citing Snowflake’s raised full-year guidance and the positive outlook for the second quarter.
- Benchmark elevated its target to $270, referencing record sequential dollar growth.
- Cantor Fitzgerald adjusted its target to $282, emphasizing the favorable impact of Snowflake's AI-driven growth narrative.
- Freedom Broker set its target at $300, highlighting the accelerated monetization of AI products such as Cortex Code.
- Truist Securities also raised its target to $275, reflecting gains observed in both core and AI workloads on the platform.
The reported data presents a complex picture: while insider sales occurred under a pre-planned schedule, the company's foundational growth metrics and subsequent analyst revisions point toward strong operational momentum. The market capitalization of $82.7 billion is supported by high revenue growth (31%), yet the underlying lack of profitability over the trailing twelve months remains a key financial consideration.